Mrs Melanie Ray Skar, PT | |
602 Main St. E, Good Samaritan Center, Mohall, ND 58761 | |
(701) 756-6831 | |
(701) 756-6357 |
Full Name | Mrs Melanie Ray Skar |
---|---|
Gender | Female |
Speciality | Physical Medicine & Rehabilitation - Neuromuscular Medicine |
Location | 602 Main St. E, Mohall, North Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003148644 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081N0008X | Physical Medicine & Rehabilitation - Neuromuscular Medicine | 1023 (North Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Melanie Ray Skar, PT Po Box 306, Melanie Ray Skar, Pt, Kenmare, ND 58746 Ph: (701) 385-3250 | Mrs Melanie Ray Skar, PT 602 Main St. E, Good Samaritan Center, Mohall, ND 58761 Ph: (701) 756-6831 |
News Archive
The only drug to receive FDA approval for reduction of the abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection may also reduce the incidence of fatty liver disease in such patients.
A new study in the Journal of General Internal Medicine, published by Springer, shows that opioid prescribing has dropped after a peak in 2012. Lead author Katherine Hadlandsmyth of the Iowa City VA Healthcare System and the University of Iowa in the US further noted that the decline was mostly due to decreases in long-term opioid prescribing, which carries much greater risk for harmful side effects, addiction and overdose, relative to short-term prescribing.
Someday, according to a new study, doctors might prescribe chocolate or cocoa to help patients with peripheral arterial disease to walk easier. The study published in February 2020 in the journal Circulation Research of the American Heart Association (AHA) reports a significant improvement in walking distance in patients following regular cocoa consumption.
Professor Matthew Disney of the Department of Chemistry on the Florida campus of The Scripps Research Institute, together with scientists from Mayo Clinic's Florida campus and Johns Hopkins School of Medicine, has been awarded $7.2 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health to create new RNA-based treatments for the most common form of amyotrophic lateral sclerosis (ALS), as well as a type of frontotemporal dementia (FTD).
Today, Veeva Systems announced that it has acquired Merqurio's healthcare professional (HCP) and healthcare organisation (HCO) database for Italy. With the acquisition of this market-leading Italian HCP and stakeholder data, Veeva OpenData now expands to a third major European market and builds on Veeva's commitment to deliver a new approach to customer reference data that is open, easy, and global.
› Verified 3 days ago